D-1166-2019 Class II Terminated
FDA drug recall D-1166-2019 was initiated by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy on April 2, 2019 and is designated Class II. Reason for recall: Lack of sterility assurance. The recall status is terminated (terminated September 24, 2021). Affected quantity: 1 vial.
Recall Details
- Product Type
- Drugs
- Report Date
- April 24, 2019
- Initiation Date
- April 2, 2019
- Termination Date
- September 24, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1 vial
Product Description
Phenylephrine 1 mg/mL Injection, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
Reason for Recall
Lack of sterility assurance.
Distribution Pattern
Nationwide
Code Information
All Lots